Cooper Cos. (COO) Misses Q4 EPS by 32c; Guides In-Line

December 5, 2013 4:04 PM
Cooper Cos. (NYSE: COO) reported Q4 EPS of $1.48, $0.32 worse than the analyst estimate of $1.80. Revenue for the quarter came in at $411.9 million versus the consensus estimate of $421.58 million.

Cooper Cos. sees FY2014 EPS of $6.70-$7.00, versus the consensus of $7.00.

Commenting on the results, Robert S. Weiss, Cooper's president and chief executive officer said, "I am pleased to report record financial results for fiscal 2013 including record revenues at both of our business units and record EPS for the Company. We are proud of our many accomplishments throughout the year including CooperVision's success with its Biofinity® family of products and launch of MyDay™ along with CooperSurgical's success with its fertility franchise. As we enter fiscal 2014, we remain encouraged by our business trends and believe we are well positioned to deliver strong operating results."

For earnings history and earnings-related data on Cooper Cos. (COO) click here.


Earnings Guidance Management Comments